Ignite Creation Date:
2024-05-06 @ 2:15 PM
Last Modification Date:
2024-10-26 @ 1:28 PM
Study NCT ID:
NCT04265872
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2020-01-23
Brief Title:
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
Sponsor:
Organization:
Baylor Research Institute